NHS Approves First Drug to Delay Type 1 Diabetes

The NHS in England and Wales has approved teplizumab, the first drug capable of delaying the onset of type 1 diabetes by up to three years.

The immunotherapy treatment works by targeting the autoimmune process that destroys insulin-producing cells.

Diabetes charities hailed the decision as a 'landmark' moment that could transform the lives of those at risk.

The approval comes after successful clinical trials showed significant delays in the progression of the disease.